Multiple Sclerosis Trial, Recruiting (NCT07492667)

Multiple Sclerosis Trial, Recruiting NCT07492667 Sponsor: Central Hospital, Nancy, France Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07492667 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are covered by the French national health insurance system
People who are visiting or staying in a neurology department at either Nancy University Hospital or Metz-Thionville Regional Hospital (Mercy site)
People who are being seen for the first time for symptoms or brain scan findings that a neurologist at one of those hospitals suspects may be related to multiple sclerosis

Who may not be able to join:

People whose symptoms or brain scan findings suggest a condition other than multiple sclerosis, such as neuromyelitis optica, MOG antibody-associated disease, sarcoidosis, conditions linked to anti-neuronal antibodies, or vascular, infectious, tumour-related, or paraneoplastic disorders
People for whom it is not possible to have at least one brain MRI scan as part of their initial assessment, for example due to a medical reason that prevents them from having an MRI

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +333383851688

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07492667

Sponsor: Central Hospital, Nancy, France

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +333383851688

More information: https://clinicaltrials.gov/study/NCT07492667

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are covered by the French national health insurance system
People who are visiting or staying in a neurology department at either Nancy University Hospital or Metz-Thionville Regional Hospital (Mercy site)
People who are being seen for the first time for symptoms or brain scan findings that a neurologist at one of those hospitals suspects may be related to multiple sclerosis

Who may not be able to join:

People whose symptoms or brain scan findings suggest a condition other than multiple sclerosis, such as neuromyelitis optica, MOG antibody-associated disease, sarcoidosis, conditions linked to anti-neuronal antibodies, or vascular, infectious, tumour-related, or paraneoplastic disorders
People for whom it is not possible to have at least one brain MRI scan as part of their initial assessment, for example due to a medical reason that prevents them from having an MRI

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Central Hospital, Nancy, France

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

31 December 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Diagnosis of MS using the 2024 criteria (diagnosis yes or no) and 2017 criteria (diagnosis yes or no) at the end of the initial assessment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov